Skip to main content
. 2015 May-Jun;90(3):367–375. doi: 10.1590/abd1806-4841.20153113

CHART 1.

Effects of the main topical medications used in psoriasis during pregnancy

Medication Adverse events in pregnancy Adverse events in animals Conclusion
Topical      
Anthralin No available data No available data Contraindicated due to the lack of available data
Calcipotriol No available data Increased incidence of skeletal abnormalities, and incomplete pubic bones ossification Contraindicated due to the lack of available data
Corticoids Intrauterine growth retardation reported Fetal growth retardation Safe, except when used in large amounts and extensive areas, when it can be associated with low birth weight
Omphalocele and umbilical hernia
Coaltar Trisomy 13, spontaneous miscarriages Fetal death, growth retardation, cleft palate, teratogenic Contraindicated due to the lack of available data
Salicylic acid Oral use causes maternal and fetal hemostasis disorders Stenosis of the ductus arterio-suswith systemic treatment Contraindicated
  Reversible stenosis of the ductus arteriosus    
  Salicylism    
Tacrolimus Low birth weight, prematurity and hyperkalemia with systemic use Malformations, fetal growth retardation, fetal death with systemic treatment Probably safe for topical use, however without enough data
Tazarotene Few data in humans Teratogenic effects and fetal death with systemic use Contraindicated